WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 41'446  41'087  40'729  40'374  40'024  36'903  32'625  28'120 
Births 694  695  695  694  693  691  709  692 
Surviving infants 687  687  687  686  684  678  691  668 
Pop. less than 5 years 3'434  3'436  3'422  3'384  3'365  3'449  3'395  3'330 
Pop. less than 15 years 10'044  10'049  10'052  10'044  10'067  10'305  10'014  8'574 
Female 15-49 years 10'467  10'372  10'276  10'182  10'084  9'142  7'767  6'758 

Number of reported case

(Click for retrospective incidence data for Argentina)
Diphtheria 31  86 
Japanese encephalitis
Measles 17  1'967  16'102 
Mumps 3'772  4'619  5'481  5'083  5'913 
Pertussis 1'112  1'239  1'594  804  1'743  515  2'012  27'223 
Polio* 32 
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 11  10  15  12  49  219 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Argentina)
Vaccine year result method % card seen                                                
BCG          100  100  99*  100  100  99  99*  62 
DTP1          94  94  94  95  94  88 
DTP3          87  91  93  94  94  83  87  44 
HepB_BD          85  88  85  85  81 
HepB3          87  91  93  94  93 
Hib3          87  91  93  94  93  83 
JapEnc         
MCV          91  94  95  99*  100  91  93  61 
MCV2          79  90  91  96  96  91 
PCV1          96  69 
PCV3          81  22 
Pol3          87  90  93  95  97  88  90  33 
Rota1         
Rota_last         
Rubella1          91  94  95  99  100 
TT2plus 2011  43  MICS     95  78  42 
PAB         
VAD1         
YFV          91  88  87  90  89 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Argentina)
BCG 99  99  99  99  99  99  99  62 
DTP1 93  94  94  95  94  96  95  69 
DTP3 87  91  92  94  94  83  87  44 
HepB3 87  91  92  94  93 
HepB_BD 85  88  85  85  81 
Hib3 87  91  92  94  93  83 
MCV 91  94  95  98  99  91  93  61 
MCV2 79  90  91  96  96  91 
PCV3 81  22 
Pol3 87  90  93  95  97  88  90  33 
Rota_last
YFV 12  14 

Number of districts in the country 511  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 61
From 80 to 89% 22
From 50 to 79% 16
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; Yes
DTaPHibHepIPV Yes From February 2013 for premature babies <1500g
DTwP 6 years; Yes
DTwPHiB 18 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepA 12 months; Yes
HepB birth; Yes Y11 school children if not yet vaccinated and adults
HIB Yes risk groups
HPV 11 years (x3) Yes
Influenza 6, 7 months; >= 65 years; Yes PW and risk groups
IPV Yes risk groups
MenACWY Yes risk groups
MMR 1, 6 years; Yes and Y11 if not yet vaccinated
MR Yes postpartum and postabortum
OPV 2, 4, 6, 18 months; 6 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps > 65 years; and risk groups
Td 16 years; Yes
Tdap 11 years; Yes HCW and PW
Varicella risk groups
YF 12 months; No risk areas

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016  2010-2015  2012-2016  2010-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 24  24  129    24  24   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 511  511    511  511  547  547 
Nº districts with DTP3 coverage >=80% number 424  430  381  349  427  139 
% of districts with DTP3 coverage >=80% From 0 to 100% 83  84    68  84  25 
Nº districts with measles (MCV1) coverage >=95% number 279  270  254  259  313     
% of districts with MCV1 coverage >=95% From 0 to 100% 55  53    51  61     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 59  100  100  100       

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.